Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001161697-19-000508)

Filing Details

Accession Number:: 0001161697-19-000508
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-27 17:02:11
Reporting Period:: 2019-11-27

Accepted Time:: 2019-11-27 17:02:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369568	Catalyst Pharmaceuticals Inc.	CPRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1279473	Gary Ingenito	355 Alhambra Circle, Suite 1250 Coral Gables FL 33134	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-27	100,000	$1.13	100,000	No	4	M	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2019-11-27	100,000	$4.66	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Acquisiton	2019-11-27	100,000	$0.00	100,000	$1.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
860,000		2024-01-03	No	4	M	Direct

Footnotes

Mr. Ingenito has advised the Company that his sale of shares was to raise funds for the purchase of a home by a family member and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies and practices. Mr. Ingenito remains an officer of the Company.
The option was granted on January 3, 2017 and previously vested in two equal annual installments.